Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 12
1997 32
1998 38
1999 42
2000 35
2001 40
2002 37
2003 31
2004 39
2005 41
2006 26
2007 29
2008 21
2009 19
2010 23
2011 22
2012 23
2013 32
2014 19
2015 21
2016 30
2017 22
2018 15
2019 27
2020 18
2021 16
2022 16
2023 16
2024 17
2025 21
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

730 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean czolmitriptan (1 results)?
Zolmitriptan.
[No authors listed] [No authors listed] 2025 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000523 Free Books & Documents. Review.
Preliminary evidence indicates that zolmitriptan levels in breastmilk are low. Amounts ingested by the infant are small and unlikely to affect the nursing infant, especially if the infant is older than 2 months. Concurrent use of propranolol might increase the zolmitrip …
Preliminary evidence indicates that zolmitriptan levels in breastmilk are low. Amounts ingested by the infant are small and unlikely …
Zolmitriptan.
Abram JA, Patel P. Abram JA, et al. 2023 Nov 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2023 Nov 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 32491581 Free Books & Documents.
Zolmitriptan is a pharmaceutical medication utilized for managing and treating acute migraines. Zolmitriptan belongs to the triptan class of drugs that targets migraine symptoms and provides relief to patients. ...
Zolmitriptan is a pharmaceutical medication utilized for managing and treating acute migraines. Zolmitriptan belongs to the tr …
Intranasal zolmitriptan.
Gawel M, Worthington I. Gawel M, et al. Expert Opin Pharmacother. 2005 Jun;6(6):1019-24. doi: 10.1517/14656566.6.6.1019. Expert Opin Pharmacother. 2005. PMID: 15952929 Review.
Intranasal zolmitriptan has recently been launched in the US and Canada and is a novel formulation of the antimigraine drug zolmitriptan. ...This article reviews the initial studies of intranasal zolmitriptan; three of the most recent studies will be examined …
Intranasal zolmitriptan has recently been launched in the US and Canada and is a novel formulation of the antimigraine drug zolmit …
Zolmitriptan (Zomig).
Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Rapoport AM, et al. Expert Rev Neurother. 2004 Jan;4(1):33-41. doi: 10.1586/14737175.4.1.33. Expert Rev Neurother. 2004. PMID: 15853613 Review.
New triptans are being released in rapid succession with each addition demonstrating some specific pharmacokinetic properties, which may be translated into clinical advantages. Zolmitriptan (Zomig) offers a range of alternatives to migraine sufferers. The conventional tabl …
New triptans are being released in rapid succession with each addition demonstrating some specific pharmacokinetic properties, which may be …
Zolmitriptan. Introduction.
Mathew N. Mathew N. Cephalalgia. 1997 Oct;17 Suppl 18:1-3. doi: 10.1177/0333102497017S1801. Cephalalgia. 1997. PMID: 9399011 Review. No abstract available.
Zolmitriptan: a review of its use in migraine.
Spencer CM, Gunasekara NS, Hills C. Spencer CM, et al. Drugs. 1999 Aug;58(2):347-74. doi: 10.2165/00003495-199958020-00016. Drugs. 1999. PMID: 10473025 Review.
Other symptoms of migraine, including nausea, photophobia and phonophobia are also alleviated with zolmitriptan. Zolmitriptan is effective in the treatment of migraine associated with menses and migraine with aura. ...Zolmitriptan has also demonstrated effica …
Other symptoms of migraine, including nausea, photophobia and phonophobia are also alleviated with zolmitriptan. Zolmitriptan …
Zolmitriptan for acute migraine attacks in adults.
Bird S, Derry S, Moore RA. Bird S, et al. Cochrane Database Syst Rev. 2014 May 21;2014(5):CD008616. doi: 10.1002/14651858.CD008616.pub2. Cochrane Database Syst Rev. 2014. PMID: 24848613 Free PMC article.
OBJECTIVES: To determine the efficacy and tolerability of zolmitriptan compared to placebo and other active interventions in the treatment of acute migraine attacks in adults. ...Zolmitriptan 2.5 mg and 5 mg benefited the same proportion of people as sumatriptan 50 …
OBJECTIVES: To determine the efficacy and tolerability of zolmitriptan compared to placebo and other active interventions in the trea …
[Zolmitriptan].
Le Jeunne C. Le Jeunne C. Presse Med. 1999 Sep 25;28(28):1525-6. Presse Med. 1999. PMID: 10526561 Review. French. No abstract available.
Zolmitriptan.
[No authors listed] [No authors listed] Can Fam Physician. 1999 Jun;45:1491-4, 1497-501. Can Fam Physician. 1999. PMID: 10386213 Free PMC article.
*Zolmitriptan has been compared with sumatriptan in a trial that showed no difference in efficacy. In particular, the recurrence rate of headache after initial relief was not lower on zolmitriptan than on sumatriptan.*The safety profile of zolmitriptan is sim …
*Zolmitriptan has been compared with sumatriptan in a trial that showed no difference in efficacy. In particular, the recurrence rate …
Zolmitriptan: differences from sumatriptan.
Goadsby PJ, Boes CJ. Goadsby PJ, et al. Curr Med Res Opin. 2001;17 Suppl 1:s46-50. doi: 10.1185/0300799039117013. Curr Med Res Opin. 2001. PMID: 12463277 Review.
Zolmitriptan is a potent 5-HT(1B/1D) agonist whose targets include the peripheral and central components of the trigeminovascular system. ...Two comparative studies have found no difference in adverse event frequency between zolmitriptan and sumatriptan....
Zolmitriptan is a potent 5-HT(1B/1D) agonist whose targets include the peripheral and central components of the trigeminovascular sys …
730 results